Peregrine Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$39.8M |
| 2 |
Cloudflare
NET
|
+$38.6M |
| 3 |
lululemon athletica
LULU
|
+$31.3M |
| 4 |
CrowdStrike
CRWD
|
+$26.2M |
| 5 |
First Interstate BancSystem
FIBK
|
+$11.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DOCU
DocuSign
DOCU
|
+$38.9M |
| 2 |
Teladoc Health
TDOC
|
+$33.6M |
| 3 |
Meta Platforms (Facebook)
META
|
+$31.8M |
| 4 |
Okta
OKTA
|
+$22.6M |
| 5 |
Lantheus
LNTH
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.26% |
| 2 | Healthcare | 18.03% |
| 3 | Financials | 14.95% |
| 4 | Consumer Discretionary | 12.53% |
| 5 | Industrials | 11.78% |
Similar funds
Peregrine Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Peregrine Capital Management held 353 positions worth $4.22B, down 15% from $4.99B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Peregrine Capital Management withdrew a net $291M in Q1 2022, closing 19 positions and reducing 195 holdings. Its most notable exit was DocuSign, an estimated $38.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Peregrine Capital Management opened a new position in Abiomed Inc worth $42.8M.
- Peregrine Capital Management's largest Q1 2022 buy was Abiomed Inc: 129,135 shares worth $42.8M.
- Peregrine Capital Management added most to Callon Petroleum Company in Q1 2022, an estimated $9.01M increase.
- Peregrine Capital Management's biggest Q1 2022 reduction was Teladoc Health, cutting an estimated $33.6M.
- Peregrine Capital Management fully exited DocuSign in Q1 2022, selling an estimated $38.9M.
- Peregrine Capital Management's ten largest holdings make up 18% of its $4.22B portfolio in Q1 2022.
- Peregrine Capital Management opened 17 new positions and closed 19 in Q1 2022.
- Peregrine Capital Management's portfolio value fell 15% quarter-over-quarter to $4.22B.
Based on Peregrine Capital Management's 13F filing for Q1 2022, filed 27 Apr 2022.